These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


189 related items for PubMed ID: 14648068

  • 1. Characteristics of the killing mechanism of human natural killer cells against hepatocellular carcinoma cell lines HepG2 and Hep3B.
    Kim HR, Park HJ, Park JH, Kim SJ, Kim K, Kim J.
    Cancer Immunol Immunother; 2004 May; 53(5):461-70. PubMed ID: 14648068
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of casein kinase 2 enhances the death ligand- and natural kiler cell-induced hepatocellular carcinoma cell death.
    Kim HR, Kim K, Lee KH, Kim SJ, Kim J.
    Clin Exp Immunol; 2008 May; 152(2):336-44. PubMed ID: 18336591
    [Abstract] [Full Text] [Related]

  • 3. Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity.
    Mirandola P, Ponti C, Gobbi G, Sponzilli I, Vaccarezza M, Cocco L, Zauli G, Secchiero P, Manzoli FA, Vitale M.
    Blood; 2004 Oct 15; 104(8):2418-24. PubMed ID: 15205263
    [Abstract] [Full Text] [Related]

  • 4. Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma.
    Yamamoto T, Nagano H, Sakon M, Wada H, Eguchi H, Kondo M, Damdinsuren B, Ota H, Nakamura M, Wada H, Marubashi S, Miyamoto A, Dono K, Umeshita K, Nakamori S, Yagita H, Monden M.
    Clin Cancer Res; 2004 Dec 01; 10(23):7884-95. PubMed ID: 15585621
    [Abstract] [Full Text] [Related]

  • 5. Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells.
    Zamai L, Ahmad M, Bennett IM, Azzoni L, Alnemri ES, Perussia B.
    J Exp Med; 1998 Dec 21; 188(12):2375-80. PubMed ID: 9858524
    [Abstract] [Full Text] [Related]

  • 6. TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells.
    Kim YS, Schwabe RF, Qian T, Lemasters JJ, Brenner DA.
    Hepatology; 2002 Dec 21; 36(6):1498-508. PubMed ID: 12447876
    [Abstract] [Full Text] [Related]

  • 7. IFN-gamma induces cell death in human hepatoma cells through a TRAIL/death receptor-mediated apoptotic pathway.
    Shin EC, Ahn JM, Kim CH, Choi Y, Ahn YS, Kim H, Kim SJ, Park JH.
    Int J Cancer; 2001 Jul 15; 93(2):262-8. PubMed ID: 11410875
    [Abstract] [Full Text] [Related]

  • 8. Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells.
    Kashii Y, Giorda R, Herberman RB, Whiteside TL, Vujanovic NL.
    J Immunol; 1999 Nov 15; 163(10):5358-66. PubMed ID: 10553060
    [Abstract] [Full Text] [Related]

  • 9. Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans.
    Ishiyama K, Ohdan H, Ohira M, Mitsuta H, Arihiro K, Asahara T.
    Hepatology; 2006 Feb 15; 43(2):362-72. PubMed ID: 16440347
    [Abstract] [Full Text] [Related]

  • 10. Expression of TNF-related apoptosis-inducing ligand in human hepatocellular carcinoma.
    Shiraki K, Yamanaka T, Inoue H, Kawakita T, Enokimura N, Okano H, Sugimoto K, Murata K, Nakano T.
    Int J Oncol; 2005 May 15; 26(5):1273-81. PubMed ID: 15809718
    [Abstract] [Full Text] [Related]

  • 11. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
    Ganten TM, Haas TL, Sykora J, Stahl H, Sprick MR, Fas SC, Krueger A, Weigand MA, Grosse-Wilde A, Stremmel W, Krammer PH, Walczak H.
    Cell Death Differ; 2004 Jul 15; 11 Suppl 1():S86-96. PubMed ID: 15105837
    [Abstract] [Full Text] [Related]

  • 12. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells.
    Kayagaki N, Yamaguchi N, Nakayama M, Takeda K, Akiba H, Tsutsui H, Okamura H, Nakanishi K, Okumura K, Yagita H.
    J Immunol; 1999 Aug 15; 163(4):1906-13. PubMed ID: 10438925
    [Abstract] [Full Text] [Related]

  • 13. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N, Poulaki V, Tseleni-Balafouta S, Koutras DA, Stamenkovic I.
    Cancer Res; 2000 Aug 01; 60(15):4122-9. PubMed ID: 10945619
    [Abstract] [Full Text] [Related]

  • 14. Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases.
    Saitou Y, Shiraki K, Fuke H, Inoue T, Miyashita K, Yamanaka Y, Yamaguchi Y, Yamamoto N, Ito K, Sugimoto K, Nakano T.
    Hum Pathol; 2005 Oct 01; 36(10):1066-73. PubMed ID: 16226105
    [Abstract] [Full Text] [Related]

  • 15. Pancreatic adenocarcinoma cell lines show variable susceptibility to TRAIL-mediated cell death.
    Ibrahim SM, Ringel J, Schmidt C, Ringel B, Müller P, Koczan D, Thiesen HJ, Löhr M.
    Pancreas; 2001 Jul 01; 23(1):72-9. PubMed ID: 11451151
    [Abstract] [Full Text] [Related]

  • 16. TRAIL-induced apoptosis of thyroid cancer cells: potential for therapeutic intervention.
    Ahmad M, Shi Y.
    Oncogene; 2000 Jul 13; 19(30):3363-71. PubMed ID: 10918593
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-2 activated NK cells do not use the CD95L- and TRAIL-pathways in the rapid induction of apoptosis of rat colon carcinoma CC531s cells.
    Velthuis JH, de Bont HJ, Medema JP, Kuppen PJ, Mulder GJ, Nagelkerke JF.
    Immunobiology; 2003 Jul 13; 207(2):115-27. PubMed ID: 12675269
    [Abstract] [Full Text] [Related]

  • 18. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
    Brando C, Mukhopadhyay S, Kovacs E, Medina R, Patel P, Catina TL, Campbell KS, Santoli D.
    J Leukoc Biol; 2005 Aug 13; 78(2):359-71. PubMed ID: 15937142
    [Abstract] [Full Text] [Related]

  • 19. Hypericin photo-induced apoptosis involves the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and activation of caspase-8.
    Schempp CM, Simon-Haarhaus B, Termeer CC, Simon JC.
    FEBS Lett; 2001 Mar 23; 493(1):26-30. PubMed ID: 11277999
    [Abstract] [Full Text] [Related]

  • 20. Midkine protects hepatocellular carcinoma cells against TRAIL-mediated apoptosis through down-regulation of caspase-3 activity.
    Ohuchida T, Okamoto K, Akahane K, Higure A, Todoroki H, Abe Y, Kikuchi M, Ikematsu S, Muramatsu T, Itoh H.
    Cancer; 2004 Jun 01; 100(11):2430-6. PubMed ID: 15160348
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.